دسترسی نامحدود
برای کاربرانی که ثبت نام کرده اند
برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید
در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید
برای کاربرانی که ثبت نام کرده اند
درصورت عدم همخوانی توضیحات با کتاب
از ساعت 7 صبح تا 10 شب
ویرایش: [5 ed.]
نویسندگان: Robert Boland. Marcia Verduin
سری:
ISBN (شابک) : 1975167481, 9781975167486
ناشر: LWW
سال نشر: 2022
تعداد صفحات: 1100
[2765]
زبان: English
فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود)
حجم فایل: 31 Mb
در صورت تبدیل فایل کتاب Kaplan & Sadock's Concise Textbook of Clinical Psychiatry به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.
توجه داشته باشید کتاب کتاب درسی مختصر روانپزشکی بالینی کاپلان و سادوک نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.
پوشش مختصر اما کاملی از کل زمینه روانپزشکی بالینی، از جمله عوامل بیولوژیکی، روانشناختی، و جامعه شناختی در سلامت و بیماری ارائه می دهد.
راهنمای گام به گام در مورد معاینه بالینی، گزارش روانپزشکی، ارزیابی پزشکی بیمار روانپزشکی ارائه می دهد. ، تست های آزمایشگاهی و علائم و نشانه ها و همچنین کلیه اختلالات روانپزشکی و مرتبط با مواد با فصل های ویژه کودکان، نوجوانان و سالمندان.
جدیدترین روشهای درمانی شامل توصیف تمام تکنیکهای رواندرمانی مدرن را ارائه میکند.
شامل تاریخچههای واقعی موردی در سراسر جهان است و واژهنامه منحصربهفردی از علائم و نشانههای روانپزشکی را در خود دارد.
شامل بهروزرسانیها و بازنگریهای کامل در سراسر جهان است که همگی با DSM-5 مطابقت دارند.
نمای کلی جامعی از جنبههای بالینی روانپزشکی را برای پزشکان، دستیاران، دانشجویان و سایر افرادی که ارائه میدهند ارائه میکند. مراقبت از سلامت روان
تجربه خواندن کتاب الکترونیکی خود را غنی کنید < /span>
مستقیماً در دستگاه(های) دلخواهتان مانند رایانه، رایانه لوحی یا تلفن هوشمند بخوانید.
به راحتی به کتاب صوتی تبدیل کنید و محتوای خود را با تبدیل متن به گفتار به زبان طبیعی تقویت کنید.
Provides concise but thorough coverage of the entire field of clinical psychiatry, including biologic, psychologic, and sociologic factors in health and disease.
Offers step-by-step guidance on the clinical examination, the psychiatric report, medical assessment of the psychiatric patient, laboratory tests, and signs and symptoms, as well as all psychiatric and substance-related disorders, with special chapters on children, adolescents, and the elderly.
Presents the most current treatment methods including descriptions of all modern psychotherapeutic techniques.
Contains real-world case histories throughout and features a unique glossary of psychiatric signs and symptoms.
Includes thorough updates and revisions throughout, all consistent with the DSM-5.
Presents a comprehensive overview of the clinical aspects of psychiatry for clinicians, residents, students, and all others who provide mental health care.
Enrich Your eBook Reading Experience
Read directly on your preferred device(s), such as computer, tablet, or smartphone.
Easily convert to audiobook, powering your content with natural language text-to-speech.
Cover Title Page Copyright Dedication Preface Contents About the Authors A Clinical Psychiatry 1. Examination and Diagnosis of the Psychiatric Patient 1.1 The Adult Patient PSYCHIATRIC INTERVIEW, HISTORY, AND MENTAL STATUS EXAMINATION PHYSICAL EXAMINATION OF THE PSYCHIATRIC PATIENT THE PSYCHIATRIC REPORT AND MEDICAL RECORD PSYCHIATRIC RATING SCALES CLINICAL NEUROPSYCHOLOGY AND INTELLECTUAL ASSESSMENT OF ADULTS PERSONALITY ASSESSMENT: ADULTS AND CHILDREN MEDICAL ASSESSMENT AND LABORATORY TESTING IN PSYCHIATRY NEUROIMAGING 1.2 Children and Adolescents CLINICAL INTERVIEWS DIAGNOSTIC INSTRUMENTS QUESTIONNAIRES AND RATING SCALES COMPONENTS OF THE CHILD PSYCHIATRIC EVALUATION INTELLECTUAL DISABILITY PSYCHIATRIC INTERVIEW AND TESTS 1.3 Geriatric Patients PSYCHIATRIC EXAMINATION OF THE OLDER PATIENT EARLY DETECTION AND PREVENTION STRATEGIES 2. Neurodevelopmental Disorders and Other Childhood Disorders 2.1 Intellectual Disability NOMENCLATURE CLASSIFICATION DEGREES OF SEVERITY OF INTELLECTUAL DISABILITY CLINICAL FEATURES DIAGNOSIS DIFFERENTIAL DIAGNOSIS COMORBIDITY COURSE AND PROGNOSIS TREATMENT EPIDEMIOLOGY ETIOLOGY 2.2 Communication Disorders LANGUAGE DISORDER SPEECH SOUND DISORDER CHILD-ONSET FLUENCY DISORDER (STUTTERING) SOCIAL (PRAGMATIC) COMMUNICATION DISORDER UNSPECIFIED COMMUNICATION DISORDER 2.3 Autism Spectrum Disorder DIAGNOSIS AND CLINICAL FEATURES DIFFERENTIAL DIAGNOSIS COURSE AND PROGNOSIS TREATMENT EPIDEMIOLOGY ETIOLOGY AND PATHOGENESIS 2.4 Attention-Deficit/Hyperactivity Disorder CLINICAL FEATURES DIAGNOSIS DIFFERENTIAL DIAGNOSIS COURSE AND PROGNOSIS TREATMENT EPIDEMIOLOGY ETIOLOGY ADULT MANIFESTATIONS OF ADHD 2.5 Specific Learning Disorder SPECIFIC LEARNING DISORDER WITH IMPAIRMENT IN READING SPECIFIC LEARNING DISORDER WITH IMPAIRMENT IN MATHEMATICS SPECIFIC LEARNING DISORDER WITH IMPAIRMENT IN WRITTEN EXPRESSION 2.6 Motor Disorders DEVELOPMENTAL COORDINATION DISORDER STEREOTYPIC MOVEMENT DISORDER TOURETTES DISORDER PERSISTENT (CHRONIC) MOTOR OR VOCAL TIC DISORDER 2.7 Feeding and Eating Disorders of Infancy or Early Childhood PICA RUMINATION DISORDER AVOIDANT/RESTRICTIVE FOOD INTAKE DISORDER 2.8 Trauma- and Stressor-Related Disorders in Children REACTIVE ATTACHMENT DISORDER AND DISINHIBITED SOCIAL ENGAGEMENT DISORDER POSTTRAUMATIC STRESS DISORDER OF INFANCY, CHILDHOOD, AND ADOLESCENCE 2.9 Depressive Disorders and Suicide in Children and Adolescents DIAGNOSIS AND CLINICAL FEATURES DIFFERENTIAL DIAGNOSIS COURSE AND PROGNOSIS TREATMENT EPIDEMIOLOGY ETIOLOGY SUICIDE 2.10 Early-Onset Bipolar Disorder DIAGNOSIS AND CLINICAL FEATURES DIFFERENTIAL DIAGNOSIS COMORBIDITY COURSE AND PROGNOSIS TREATMENT EPIDEMIOLOGY ETIOLOGY 2.11 Disruptive Mood Dysregulation Disorder DIAGNOSIS AND CLINICAL FEATURES DIFFERENTIAL DIAGNOSIS COMORBIDITY COURSE AND PROGNOSIS TREATMENT EPIDEMIOLOGY 2.12 Disruptive Behaviors of Childhood OPPOSITIONAL DEFIANT DISORDER CONDUCT DISORDER 2.13 Anxiety Disorders of Infancy, Childhood, and Adolescence: Separation Anxiety Disorder, Generalized Anxiety Disorder, and Social Anxiety Disorder (Social Phobia) SEPARATION ANXIETY DISORDER GENERALIZED ANXIETY DISORDER SOCIAL ANXIETY DISORDER (SOCIAL PHOBIA) DIAGNOSIS AND CLINICAL FEATURES DIFFERENTIAL DIAGNOSIS COURSE AND PROGNOSIS TREATMENT EPIDEMIOLOGY ETIOLOGY 2.14 Selective Mutism DIAGNOSIS AND CLINICAL FEATURES DIFFERENTIAL DIAGNOSIS COURSE AND PROGNOSIS TREATMENT EPIDEMIOLOGY ETIOLOGY 2.15 Obsessive-Compulsive Disorder in Childhood and Adolescence DIAGNOSIS AND CLINICAL FEATURES DIFFERENTIAL DIAGNOSIS COURSE AND PROGNOSIS TREATMENT EPIDEMIOLOGY ETIOLOGY 2.16 Early-Onset Schizophrenia DIAGNOSIS AND CLINICAL FEATURES DIFFERENTIAL DIAGNOSIS COURSE AND PROGNOSIS TREATMENT EPIDEMIOLOGY ETIOLOGY ATTENUATED PSYCHOSIS SYNDROME 2.17 Adolescent Substance Use Disorders DIAGNOSIS AND CLINICAL FEATURES COMORBIDITY TREATMENT EPIDEMIOLOGY ETIOLOGY 3. Neurocognitive Disorders DEFINITION CLINICAL EVALUATION PATHOLOGY AND LABORATORY EXAMINATION 3.1 Delirium DIAGNOSIS AND CLINICAL FEATURES PHYSICAL AND LABORATORY EXAMINATIONS DIFFERENTIAL DIAGNOSIS COURSE AND PROGNOSIS TREATMENT EPIDEMIOLOGY ETIOLOGY 3.2 Dementia (Major Neurocognitive Disorder) DIAGNOSIS AND CLINICAL FEATURES DIFFERENTIAL DIAGNOSIS COURSE AND PROGNOSIS TREATMENT EPIDEMIOLOGY ETIOLOGY 3.3 Major or Minor Neurocognitive Disorder due to Another Medical Condition (Amnestic Disorders) DIAGNOSIS CLINICAL FEATURES AND SUBTYPES PATHOLOGY AND LABORATORY EXAMINATION DIFFERENTIAL DIAGNOSIS COURSE AND PROGNOSIS TREATMENT EPIDEMIOLOGY ETIOLOGY 3.4 Neurocognitive and Other Psychiatric Disorders due to a General Medical Condition SPECIFIC DISORDERS 3.5 Mild Cognitive Impairment DEFINITION CLINICAL PRESENTATION COURSE AND PROGNOSIS TREATMENT EPIDEMIOLOGY AND ETIOLOGY OF MCI 4. Substance Use and Addictive Disorders 4.1 General Features of the Substance-Related Disorders THE CLINICAL PRESENTATION DIAGNOSIS COMORBIDITY TREATMENT APPROACH ETIOLOGY 4.2 Alcohol-Related Disorders DIAGNOSIS AND CLINICAL FEATURES COMORBIDITY COURSE AND PROGNOSIS TREATMENT OF ALCOHOL USE DISORDERS PATHOLOGY ETIOLOGY 4.3 Cannabis-Related Disorders CLINICAL FEATURES DIAGNOSIS COMORBIDITY TREATMENT AND REHABILITATION EPIDEMIOLOGY PATHOLOGY 4.4 Opioid-Related Disorders CLINICAL FEATURES COMORBIDITY TREATMENT AND REHABILITATION EPIDEMIOLOGY PATHOLOGY ETIOLOGY 4.5 Sedative-, Hypnotic-, or Anxiolytic-Related Disorders DIAGNOSIS TREATMENT AND REHABILITATION EPIDEMIOLOGY PATHOLOGY 4.6 Stimulant-Related Disorders CLINICAL FEATURES DIAGNOSIS COMORBIDITY TREATMENT AND REHABILITATION EPIDEMIOLOGY PATHOLOGY ETIOLOGY 4.7 Tobacco-Related Disorders CLINICAL FEATURES DIAGNOSIS TREATMENT EPIDEMIOLOGY PATHOLOGY 4.8 Caffeine-Related Disorders CLINICAL FEATURES AND DIAGNOSIS COMORBIDITY TREATMENT EPIDEMIOLOGY PATHOLOGY AND ETIOLOGY 4.9 Hallucinogen-Related Disorders CLINICAL FEATURES DIAGNOSIS TREATMENT EPIDEMIOLOGY PATHOLOGY 4.10 Inhalant-Related Disorders CLINICAL FEATURES DIAGNOSIS TREATMENT EPIDEMIOLOGY 4.11 Anabolic-Androgenic Steroid Use CLINICAL FEATURES AND DIAGNOSIS TREATMENT EPIDEMIOLOGY PATHOLOGY ETIOLOGY 4.12 Gambling Disorder CLINICAL FEATURES DIAGNOSIS DIFFERENTIAL DIAGNOSIS COMORBIDITY COURSE AND PROGNOSIS TREATMENT EPIDEMIOLOGY ETIOLOGY 4.13 Other Disorders Related to the Addictive Disorders INTERNET GAMING DISORDER MOBILE OR CELL PHONE COMPULSION REPETITIVE SELF-MUTILATION COMPULSIVE SEXUAL BEHAVIOR 5. Schizophrenia Spectrum and Other Psychotic Disorders THE CLINICAL PRESENTATION DIAGNOSIS OBJECTIVE TESTS FOR THE DISORDER DIFFERENTIAL DIAGNOSIS FOR PSYCHOTIC DISORDERS COMORBIDITY COURSE PROGNOSIS TREATMENT APPROACH THE EPIDEMIOLOGY OF THE DISORDERS THE NEUROBIOLOGY OF THE DISORDER THE PSYCHOLOGY OF THE DISORDER ETIOLOGY 6. Bipolar Disorders THE CLINICAL PRESENTATION DIAGNOSIS DIFFERENTIAL DIAGNOSIS COMORBIDITY COURSE PROGNOSIS TREATMENT APPROACH THE EPIDEMIOLOGY OF THE DISORDER(S) THE NEUROBIOLOGY OF THE DISORDER THE PSYCHOLOGY OF THE DISORDER ETIOLOGY 7. Depressive Disorders THE CLINICAL PRESENTATION DIAGNOSIS DIFFERENTIAL DIAGNOSIS COMORBIDITY COURSE PROGNOSIS TREATMENT APPROACH THE EPIDEMIOLOGY OF DEPRESSION THE NEUROBIOLOGY OF DEPRESSION THE PSYCHOLOGY OF DEPRESSION ETIOLOGY 8. Anxiety Disorders THE CLINICAL PRESENTATION DIAGNOSIS DIFFERENTIAL DIAGNOSIS COMORBIDITY COURSE TREATMENT APPROACH THE EPIDEMIOLOGY OF THE DISORDER(S) THE NEUROBIOLOGY OF THE DISORDER ETIOLOGY 9. Obsessive-Compulsive and Related Disorders THE CLINICAL PRESENTATION DIAGNOSIS DIFFERENTIAL DIAGNOSIS COMORBIDITY COURSE AND PROGNOSIS TREATMENT EPIDEMIOLOGY ETIOLOGY 10. Trauma- and Stressor-Related Disorders THE CLINICAL PRESENTATION DIAGNOSIS DIFFERENTIAL DIAGNOSIS FOR THE TRAUMA- AND STRESSOR-RELATED DISORDERS COMORBIDITY COURSE AND PROGNOSIS TREATMENT APPROACH EPIDEMIOLOGY ETIOLOGY 11. Dissociative Disorders DIAGNOSTIC AND CLINICAL FEATURES DEPERSONALIZATION/DEREALIZATION DISORDER DISSOCIATIVE IDENTITY DISORDER OTHER SPECIFIED OR UNSPECIFIED DISSOCIATIVE DISORDER COMORBIDITY COURSE AND PROGNOSIS TREATMENT EPIDEMIOLOGY ETIOLOGY 12. Somatic Symptom and Related Disorders THE CLINICAL PRESENTATION DIAGNOSIS EVALUATION OF SOMATIC SYMPTOM AND RELATED DISORDERS DIFFERENTIAL DIAGNOSIS COMORBIDITY COURSE AND PROGNOSIS TREATMENT OF SOMATIC SYMPTOM AND RELATED DISORDERS EPIDEMIOLOGY ETIOLOGY 13. Feeding and Eating Disorders CLINICAL FEATURES DIAGNOSIS AND CLINICAL FEATURES PATHOLOGY AND LABORATORY EXAMINATION DIFFERENTIAL DIAGNOSIS COMORBIDITY COURSE AND PROGNOSIS TREATMENT APPROACH EPIDEMIOLOGY ETIOLOGY 14. Elimination Disorders ENCOPRESIS ENURESIS 15. Sleep–Wake Disorders THE CLINICAL PRESENTATION DIAGNOSIS CLINICAL TOOLS IN SLEEP MEDICINE DIFFERENTIAL DIAGNOSIS COMORBIDITY TREATMENT APPROACH 16. Human Sexuality and Sexual Dysfunctions SEXUAL DYSFUNCTIONS PARAPHILIC DISORDERS SEX ADDICTION AND COMPULSIVITY NORMAL SEXUALITY 17. Gender Dysphoria, Gender Identity, and Related Conditions INTRODUCTION DIAGNOSIS AND CLINICAL FEATURES DIFFERENTIAL DIAGNOSIS COURSE AND PROGNOSIS COMORBIDITY TREATMENT EPIDEMIOLOGY ETIOLOGY 18. Disruptive, Impulse-Control, and Conduct Disorders THE CLINICAL PRESENTATION DIAGNOSIS OBJECTIVE TESTS FOR THE DISORDERS DIFFERENTIAL DIAGNOSIS FOR THE DISRUPTIVE AND IMPULSE-CONTROL DISORDERS COMORBIDITY COURSE AND PROGNOSIS TREATMENT APPROACH EPIDEMIOLOGY ETIOLOGY 19. Personality Disorders THE CLINICAL PRESENTATION DIAGNOSIS DIFFERENTIAL DIAGNOSIS COMORBIDITY COURSE AND PROGNOSIS TREATMENT APPROACH EPIDEMIOLOGY ETIOLOGY 20. Other Conditions that May be a Focus of Clinical Attention INTRODUCTION MALINGERING BEREAVEMENT OCCUPATIONAL PROBLEMS ADULT ANTISOCIAL BEHAVIOR RELIGIOUS OR SPIRITUAL PROBLEM ACCULTURATION PROBLEM PHASE OF LIFE PROBLEM NONCOMPLIANCE WITH TREATMENT RELATIONAL PROBLEMS B Treatment Across the Lifespan 21. Psychopharmacology DRUG SELECTION DRUG FACTORS SIDE EFFECTS PATIENT-RELATED FACTORS INFORMED CONSENT AND PATIENT EDUCATION DOSING, DURATION, AND MONITORING LABORATORY TESTS AND THERAPEUTIC BLOOD MONITORING TREATMENT OUTCOMES COMBINATION OF DRUGS COMBINED PSYCHOTHERAPY AND PHARMACOTHERAPY SPECIAL POPULATIONS REGULATORY ISSUES NONAPPROVED DOSAGES AND USES PLACEBOS 21.1 Antipsychotics SEROTONIN–DOPAMINE ANTAGONISTS AND SIMILARLY ACTING DRUGS (SECOND-GENERATION OR ATYPICAL ANTIPSYCHOTICS) DOPAMINE RECEPTOR ANTAGONISTS (FIRST-GENERATION ANTIPSYCHOTICS) 21.2 Antidepressants SELECTIVE SEROTONIN REUPTAKE INHIBITORS SELECTIVE SEROTONIN–NOREPINEPHRINE REUPTAKE INHIBITORS BUPROPION MIRTAZAPINE NEFAZODONE AND TRAZODONE TRICYCLICS AND TETRACYCLICS MONOAMINE OXIDASE INHIBITORS THYROID HORMONES NOVEL AGENTS 21.3 Mood Stabilizers LITHIUM VALPROATE LAMOTRIGINE CARBAMAZEPINE AND OXCARBAZEPINE OTHER ANTICONVULSANTS CALCIUM CHANNEL BLOCKERS 21.4 Anxiolytics BENZODIAZEPINES AND DRUGS ACTING ON GABA RECEPTORS BUSPIRONE β-Adrenergic Receptor Antagonists BARBITURATES AND SIMILARLY ACTING DRUGS 21.5 Drugs Used to Treat Sleep Disorders NONBENZODIAZEPINE GABA AGONISTS MELATONIN AGONISTS: RAMELTEON AND MELATONIN PRAZOSIN 21.6 Stimulants STIMULANT DRUGS AND ATOMOXETINE ATOMOXETINE (STRATTERA) 21.7 Drugs Used to Treat Substance Use Disorders OPIOID RECEPTOR AGONISTS OPIOID RECEPTOR ANTAGONISTS: NALTREXONE, NALMEFENE, AND NALOXONE DISULFIRAM AND ACAMPROSATE CLONIDINE AND GUANFACINE 21.8 Drugs Used for Cognitive Enhancement CHOLINESTERASE INHIBITORS MEMANTINE 21.9 Drugs Used to Treat Sexual Disorders PHOSPHODIESTERASE-5 INHIBITORS YOHIMBINE 21.10 Drugs Used to Treat the Side Effects of Psychotropic Drugs ANTICHOLINERGIC AGENTS ANTIHISTAMINES DOPAMINE RECEPTOR AGONISTS AND PRECURSORS DRUGS TO TREAT PSYCHOTROPIC-INDUCED WEIGHT GAIN 21.11 Nutritional Supplements and Related NUTRITIONAL SUPPLEMENTS AND MEDICAL FOODS PHYTOMEDICINES 22. Other Somatic Therapies ELECTROCONVULSIVE THERAPY OTHER BRAIN STIMULATION METHODS NEUROSURGICAL TREATMENTS AND DEEP BRAIN STIMULATION 23. Psychotherapy PSYCHOANALYSIS AND PSYCHOANALYTIC PSYCHOTHERAPY BRIEF PSYCHODYNAMIC PSYCHOTHERAPY GROUP PSYCHOTHERAPY, COMBINED INDIVIDUAL AND GROUP PSYCHOTHERAPY, AND PSYCHODRAMA FAMILY THERAPY AND COUPLES THERAPY DIALECTICAL BEHAVIOR THERAPY BIOFEEDBACK COGNITIVE THERAPY BEHAVIOR THERAPY HYPNOSIS INTERPERSONAL THERAPY NARRATIVE PSYCHOTHERAPY COMBINED PSYCHOTHERAPY AND PHARMACOTHERAPY MENTALIZATION-BASED TREATMENT PSYCHOEDUCATIONAL INTERVENTIONS 24. Psychiatric Rehabilitation and Other Interventions PSYCHIATRIC REHABILITATION GENETIC COUNSELING 25. Consultation to Other Disciplines 25.1 Consultation-Liaison Psychiatry HISTORY CURRENT TRENDS EVALUATION PROCESS IN PSYCHOSOMATIC MEDICINE TREATMENTS USED IN PSYCHOSOMATIC MEDICINE PSYCHO-ONCOLOGY 25.2 Geriatric Psychiatry PSYCHIATRIC PROBLEMS OF OLDER PERSONS MENTAL DISORDERS OF OLD AGE SUICIDE RISK OTHER CONDITIONS OF OLD AGE SPOUSAL BEREAVEMENT PSYCHOPHARMACOLOGICAL TREATMENT OF GERIATRIC DISORDERS PSYCHOTHERAPY FOR GERIATRIC PATIENTS 25.3 Psychiatric Emergencies TREATMENT SETTINGS EPIDEMIOLOGY EVALUATION SPECIFIC INTERVIEW SITUATIONS TREATMENT OF EMERGENCIES PSYCHIATRIC EMERGENCIES IN CHILDREN 26. Level of Care INPATIENT ADMISSION PARTIAL HOSPITAL TREATMENT INTENSIVE OUTPATIENT TREATMENT OUTPATIENT CARE RESIDENTIAL CARE C Other Issues Relevant to Psychiatry 27. Ethics and Professionalism PROFESSIONAL CODES BASIC ETHICAL PRINCIPLES SPECIFIC ISSUES 28. Forensic and Legal Issues MEDICAL MALPRACTICE PRIVILEGE AND CONFIDENTIALITY HIGH-RISK CLINICAL SITUATIONS HOSPITALIZATION RIGHT TO TREATMENT RIGHT TO REFUSE TREATMENT CIVIL RIGHTS OF PATIENTS SECLUSION AND RESTRAINT INFORMED CONSENT CHILD CUSTODY TESTAMENTARY AND CONTRACTUAL CAPACITY AND COMPETENCE CRIMINAL LAW OTHER AREAS OF FORENSIC PSYCHIATRY 29. End-of-Life Issues and Palliative Care 29.1 Death, Dying, and Bereavement DEATH AND DYING BEREAVEMENT, GRIEF, AND MOURNING LIFE CYCLE PERSPECTIVES ABOUT BEREAVEMENT 29.2 Palliative Care PREVALENCE GENERAL TREATMENT PRINCIPLES ANXIETY IN PATIENTS WITH ADVANCED DISEASE DEPRESSION IN PATIENTS WITH ADVANCED DISEASE CONFUSIONAL STATES IN PATIENTS WITH ADVANCED DISEASE DISEASE-SPECIFIC CONSIDERATIONS PATIENT–FAMILY UNIT DECISION POINTS, ADVANCE DIRECTIVES, PROXIES, AND SURROGATES CARING FOR THE DYING PATIENT COMMUNICATION TERMINAL CARE DECISIONS CARING FOR THE FAMILY PALLIATIVE CARE PAIN MANAGEMENT PALLIATION OF OTHER SYMPTOMS HOSPICE CARE NEONATAL AND INFANT END-OF-LIFE CARE CHILD END-OF-LIFE CARE SPIRITUAL ISSUES ALTERNATIVE AND COMPLEMENTARY MEDICINE 29.3 Euthanasia and Physician-Assisted Suicide EUTHANASIA PHYSICIAN-ASSISTED SUICIDE FUTURE DIRECTIONS 30. Community Psychiatry INTRODUCTION CONTEMPORARY PUBLIC AND COMMUNITY PSYCHIATRY THE ROLE OF PUBLIC AND COMMUNITY PSYCHIATRY IN TWENTY-FIRST CENTURY HEALTH CARE 31. Global and Cultural Issues in Psychiatry PREVALENCE AND BURDEN OF MENTAL DISORDERS WORLDWIDE TREATMENT GAP AND PROJECTED POPULATION-LEVEL TREATMENT EFFECTIVENESS WORLDWIDE RESOURCES FOR MENTAL HEALTH CARE WORLDWIDE PRINCIPLES FOR MENTAL HEALTH PROGRAM DEVELOPMENT AND BARRIERS TO CHANGE WORLDWIDE STIGMATIZING ATTITUDES TOWARD PEOPLE WITH MENTAL DISORDERS RELATIONSHIPS BETWEEN MENTAL AND PHYSICAL DISEASES ETHICAL ISSUES IN MENTAL HEALTH CARE INTERNATIONAL ORGANIZATIONS ACTIVE IN THE MENTAL HEALTH FIELD FUTURE PERSPECTIVES Glossary of Terms Relating to Signs and Symptoms Index